Aclaris Therapeutics Honored as One of the Best Places to Work in Pennsylvania
October 28 2016 - 8:00AM
Aclaris Therapeutics, Inc., (NASDAQ:ACRS), a dermatologist-led,
specialty pharmaceutical company focused on the development of
medical and aesthetic dermatology treatments, has been named one of
the Best Places to Work in PA for 2016 by the Best Companies Group.
The awards program, created in 2000, is one of the first statewide
programs of its kind in the country. The program is a
public/private partnership between Team Pennsylvania Foundation,
the Pennsylvania Department of Community and Economic Development,
the Pennsylvania State Council of the Society for Human Resource
Management, and the Central Penn Business Journal.
“It is a great honor to be named one of the Best Places to Work
in Pennsylvania, and I’m pleased to share this award with all of my
colleagues who help make Aclaris an exceptional company,” said Dr.
Neal Walker, President and Chief Executive Officer of Aclaris. “We
have built an extraordinary team of people who are committed to
developing and commercializing new medical and aesthetic
dermatology treatment options for patients with visible skin and
hair conditions.”
This survey and awards program was designed to identify,
recognize and honor the best places of employment in Pennsylvania,
who are benefiting the state's economy and its workforce. Employers
are categorized based upon the total number of employees they have
in the United States, 25 to 249 employees and 250 or more
employees.
To be considered for participation, companies had to fulfill the
following eligibility requirements:- Be a for-profit or
not-for-profit business- Be a publicly or privately held business-
Have a facility in Pennsylvania- Have at least 25 employees working
in Pennsylvania- Be in business a minimum of one year.
Companies from across the state entered the two-part process to
determine the 100 Best Places to Work in PA. The first part of this
process was evaluating each nominated company's workplace policies,
practices, philosophies, systems and demographics. This part of the
process was worth approximately 25% of the total evaluation. The
second part consisted of an employee survey to measure the employee
experience. This part of the process was worth approximately 75% of
the total evaluation. The combined scores determined the top
companies and the final ranking. Best Companies Group managed the
overall registration and survey process.
Aclaris will be recognized at the Best Places to Work in PA
awards banquet on Thursday, December 1, 2016, at the Lancaster
County Convention Center in Lancaster, PA. Rankings will be
revealed at the ceremony. Tickets may be purchased online at
www.CPBJ.com/events.
In addition to the public/private partnership, the program is
supported by the following organizations: Lead Sponsor—Team
Pennsylvania Foundation; Presenting Sponsors—BDO, USA and Conrad
Siegel Actuaries; Major Sponsors—Harrisburg University, PA
Department of Labor and Industry, Office of Vocational
Rehabilitation and Saul Ewing LLP; Selfie Sponsor—CenturyLink;
Founding Partners—Team Pennsylvania Foundation and the Central Penn
Business Journal; Program Partners—The Department of Community and
Economic Development and PA SHRM.
For more information on the Best Places to Work in PA, visit
www.bestplacestoworkinpa.com or contact Emily Winslow, event
coordinator at the Central Penn Business Journal at 717-236-4300 or
emilyw@cpbj.com.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a clinical-stage specialty pharmaceutical
company focused on identifying, developing, and commercializing
innovative and differentiated drugs to address significant unmet
needs in dermatology. Aclaris is based in Malvern, Pennsylvania and
more information can be found by visiting Aclaris’ website at
www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Vice President / Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024